首页> 外文期刊>Bulletin of experimental biology and medicine >Inhibition of thrombin activity with DNA-aptamers.
【24h】

Inhibition of thrombin activity with DNA-aptamers.

机译:用DNA适体抑制凝血酶活性。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The effects of two DNA aptamers (oligonucleotides) 15TBA and 31TBA (15- and 31-mer thrombin-binding aptamers, respectively) on thrombin activity were studied. Both aptamers added to human plasma dose-dependently increased thrombin time (fibrin formation upon exposure to exogenous thrombin), prothrombin time (clotting activation by the extrinsic pathway), and activated partial thromboplastin time (clotting activation by the intrinsic pathway). At the same time, these aptamers did not modify amidolytic activity of thrombin evaluated by cleavage of synthetic chromogenic substrate. Aptamers also inhibited thrombin-induced human platelet aggregation. The inhibitory effects of 31TBA manifested at lower concentrations than those of 15TBA in all tests. These data indicate that the studied antithrombin DNA aptamers effectively suppress its two key reactions, fibrin formation and stimulation of platelet aggregation, without modifying active center of the thrombin molecule.
机译:研究了两种DNA适体(寡核苷酸)15TBA和31TBA(分别与15和31-mer凝血酶结合的适体)对凝血酶活性的影响。两种适体添加到人血浆中的剂量依赖性地增加了凝血酶时间(暴露于外源性凝血酶时血纤蛋白形成),凝血酶原时间(通过外在途径引起的凝血激活)和活化的部分凝血活酶时间(通过内在途径引起的凝血激活)。同时,这些适体没有改变通过合成发色底物的裂解评估的凝血酶的酰胺分解活性。适体还抑制凝血酶诱导的人血小板聚集。在所有测试中,31TBA的抑制作用均低于15TBA的浓度。这些数据表明,所研究的抗凝血酶DNA适体有效地抑制了其两个关键反应,即纤维蛋白的形成和对血小板聚集的刺激,而没有改变凝血酶分子的活性中心。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号